Access and Notification:	Make available to all Epi-X users
Distribution: Contributor’s instructions for distributing this report.	Release outside of Epi-X as needed
Brief Summary of Report:	Am2Pat is expanding its recall to include all distributed lots of prefilled heparin and saline flush syringes. Please report possibly related cases to CDC's David Blossom at dblossom@cdc.gov.
Description:	CDC has been notified that Am2Pat intends to extend the recall of prefilled heparin and saline flush syringes to encompass all distributed lots of these products, because of concerns these syringes may be contaminated with Serratia marcescens. On December 20, 2007, Am2Pat recalled one lot of prefilled heparin flush syringes (http://www.fda.gov/oc/po/firmrecalls/am2pat12_07.html). CDC has been informed that the recall will now apply to all prefilled heparin and saline flush syringes made by Am2Pat. These syringes were manufactured by Am2Pat and may be labeled as: Am2Pat, Sierra Pre-filled, or B. Braun. These products will all bear the National Drug Code or NDC prefix of: 64054. They have been distributed to in-patient and out-patient facilities and directly to patients by home-care companies. Patients and clinicians should immediately stop using these products. Persons who have questions regarding the manufacturer of prefilled syringes they are using should call the supply company that provided the syringes.

http://cdc.gov/